Total Payments
$8,747
2024 Payments
$64.46
Companies
26
Transactions
203
Medicare Patients
1,313
Medicare Billing
$263,564
Payment Breakdown by Category
Travel$4,555 (52.1%)
Food & Beverage$2,599 (29.7%)
Other$1,551 (17.7%)
Education$41.20 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $4,555 | 8 | 52.1% |
| Food and Beverage | $2,599 | 179 | 29.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,551 | 15 | 17.7% |
| Education | $41.20 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Research & Development, LLC | $2,914 | 4 | $0 (2017) |
| Merck Sharp & Dohme LLC | $2,049 | 30 | $0 (2023) |
| Amgen Inc. | $1,919 | 37 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $469.62 | 20 | $0 (2022) |
| PFIZER INC. | $274.84 | 31 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $206.11 | 20 | $0 (2020) |
| Genentech USA, Inc. | $164.32 | 12 | $0 (2019) |
| Celgene Corporation | $103.10 | 6 | $0 (2024) |
| Exelixis Inc. | $80.04 | 4 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $78.19 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $64.46 | 4 | Celgene Corporation ($41.99) |
| 2023 | $99.62 | 5 | Celgene Corporation ($61.11) |
| 2022 | $97.25 | 2 | E.R. Squibb & Sons, L.L.C. ($74.62) |
| 2021 | $100.40 | 1 | E.R. Squibb & Sons, L.L.C. ($100.40) |
| 2020 | $46.68 | 3 | Novartis Pharmaceuticals Corporation ($17.67) |
| 2019 | $783.69 | 34 | Amgen Inc. ($434.99) |
| 2018 | $632.53 | 60 | PFIZER INC. ($125.43) |
| 2017 | $6,922 | 94 | Janssen Research & Development, LLC ($2,914) |
All Payment Transactions
203 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $22.47 | General |
| Category: Interventional Oncology | ||||||
| 07/17/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $13.19 | General |
| 06/20/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $14.58 | General |
| 01/23/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $14.22 | General |
| Category: Hematology | ||||||
| 08/08/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $15.92 | General |
| Category: Hematology/Oncology | ||||||
| 04/20/2023 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $20.48 | General |
| Category: Oncology | ||||||
| 02/16/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $21.33 | General |
| Category: Hematology | ||||||
| 01/25/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: ONCOLOGY | ||||||
| 01/24/2023 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $19.30 | General |
| Category: Oncology | ||||||
| 11/02/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: ONCOLOGY | ||||||
| 04/28/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $74.62 | General |
| Category: Cardiovascular | ||||||
| 08/03/2021 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $100.40 | General |
| Category: Oncology | ||||||
| 03/10/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2020 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: ONCOLOGY | ||||||
| 01/23/2020 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Oncology | ||||||
| 12/19/2019 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: BioOncology | ||||||
| 12/05/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Anemia | ||||||
| 11/20/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2019 | Amgen Inc. | MVASI (Biological), Neulasta, Vectibix | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Oncology | ||||||
| 11/12/2019 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Oncology | ||||||
| 11/07/2019 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), SANDOSTATIN, VOTRIENT | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/17/2019 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla, TECENTRIQ | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: BioOncology | ||||||
| 10/08/2019 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 316 | 632 | $158,192 | $70,479 |
| 2022 | 6 | 305 | 606 | $132,350 | $63,289 |
| 2021 | 9 | 339 | 694 | $132,430 | $68,937 |
| 2020 | 8 | 353 | 728 | $117,940 | $60,860 |
Total Patients
1,313
Total Services
2,660
Medicare Billing
$263,564
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 91 | 272 | $78,698 | $36,046 | 45.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 160 | 280 | $57,422 | $24,126 | 42.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 32 | 32 | $11,424 | $5,055 | 44.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 31 | $5,208 | $2,920 | 56.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $5,440 | $2,333 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 351 | $69,105 | $32,204 | 46.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 66 | 129 | $36,231 | $17,570 | 48.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 29 | $8,890 | $4,569 | 51.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 27 | 27 | $9,313 | $4,498 | 48.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 49 | $5,426 | $2,745 | 50.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 21 | $3,385 | $1,704 | 50.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 162 | 449 | $82,130 | $43,156 | 52.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 45 | 70 | $17,800 | $9,767 | 54.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 21 | 22 | $6,600 | $3,540 | 53.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 21 | 21 | $6,855 | $3,267 | 47.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 25 | 52 | $5,720 | $2,891 | 50.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 33 | $4,300 | $1,846 | 42.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 23 | $3,565 | $1,824 | 51.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $2,860 | $1,329 | 46.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 13 | $2,600 | $1,315 | 50.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 163 | 456 | $70,995 | $36,166 | 50.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 37 | 67 | $14,130 | $7,693 | 54.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 37 | 71 | $7,810 | $4,170 | 53.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 24 | 24 | $7,200 | $3,947 | 54.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 17 | 17 | $5,200 | $2,631 | 50.6% |
About Dr. Amit Jain, M.D
Dr. Amit Jain, M.D is a Internal Medicine healthcare provider based in Tallahassee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1144430992.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amit Jain, M.D has received a total of $8,747 in payments from pharmaceutical and medical device companies, with $64.46 received in 2024. These payments were reported across 203 transactions from 26 companies. The most common payment nature is "Travel and Lodging" ($4,555).
As a Medicare-enrolled provider, Jain has provided services to 1,313 Medicare beneficiaries, totaling 2,660 services with total Medicare billing of $263,564. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location Tallahassee, FL
- Active Since 05/23/2007
- Last Updated 08/06/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1144430992
Products in Payments
- IMLYGIC (Biological) $1,551
- KEYTRUDA (Biological) $341.39
- OPDIVO (Biological) $340.70
- ELIQUIS (Drug) $202.20
- Neulasta (Biological) $121.12
- XARELTO (Drug) $78.19
- JADENU (Drug) $76.96
- Nplate (Biological) $76.36
- Kyprolis (Biological) $72.96
- CHANTIX (Drug) $60.38
- Imbruvica (Drug) $58.61
- INJECTAFER (Drug) $56.62
- Aranesp (Biological) $51.99
- Lenvima (Drug) $51.88
- GILOTRIF (Drug) $49.46
- JAKAFI (Drug) $48.16
- VENCLEXTA (Biological) $40.53
- OPDUALAG (Drug) $39.78
- Cabometyx (Drug) $38.84
- IBRANCE (Drug) $38.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tallahassee
Dr. Gian-Carlo Giove, Md, MD
Internal Medicine — Payments: $203,800
Internal Medicine $203,800
Yvette Mignon, Md, MD
Internal Medicine — Payments: $23,151
Internal Medicine $23,151
Dr. Venkata Bavikati, Mbbs, Mph, MBBS, MPH
Internal Medicine — Payments: $21,691
Internal Medicine $21,691
Dr. Gregory Hartlage, M.d, M.D
Internal Medicine — Payments: $12,301
Internal Medicine $12,301
Dr. Shaun Laurie, M.d, M.D
Internal Medicine — Payments: $10,427
Internal Medicine $10,427
Hiyam Abdelmagid, M.d, M.D
Internal Medicine — Payments: $9,429
Internal Medicine $9,429